St. Jude Children’s Research Hospital Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:St. Jude Children’s Research Hospital Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013591
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
St. Jude Children’s Research Hospital Inc (St. Jude) is a healthcare service provider that offers research and clinical care services for children with catastrophic diseases. The hospital provides treatment programs such as brain tumors, leukemia, infectious diseases, immunodeficiency diseases, blood disorders, sickle cell disease and solid tumors, among others. It offers clinical programs such as bone marrow transplant, cancer predisposition, radiation oncology and surgery, among others. St. Jude provides research programs including cancer biology program, cancer prevention and control program, developmental biology and solid tumor program, hematological malignancies program and neurobiology and brain tumor program, among others. The hospital operates through its affiliate clinics. St. Jude is headquartered in Memphis, Tennessee, the US.

St. Jude Children’s Research Hospital Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
St. Jude Children’s Research Hospital Inc, Medical Devices Deals, 2011 to YTD 2017 11
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Serum Institute of India Enters into Licensing Agreement with St. Jude Children’s Research Hospital 13
NanoViricides Enters into Agreement with St. Jude Children’s Research Hospital 14
Cesca Therapeutics Enters into Agreement with St. Jude Children’s Research Hospital 15
Eisai Enters into Research Agreement with St. Jude Children’s Research Hospital and Medicines For Malaria Venture to Develop SJ733 16
Retrophin Enters Into Research Agreement With St. Jude Children’s Research Hospital 17
Licensing Agreements 18
Calimmune Enters into Licensing Agreement with St. Jude Children’s Research Hospital 18
Juno Therapeutics Enters into Licensing Agreement with St. Jude Children’s Research Hospital 19
Ultragenyx Pharmaceutical Enters Into Licensing Agreement with St. Jude Children’s Research Hospital 20
BioMarin Pharma Enters Into Licensing Agreement With University College London And St. Jude Children’s Research Hospital For Hemophilia A Gene Therapy Program 21
St. Jude Children’s Research Hospital Inc – Key Competitors 23
St. Jude Children’s Research Hospital Inc – Key Employees 24
St. Jude Children’s Research Hospital Inc – Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Corporate Communications 26
Jan 30, 2017: Stephen Gottschalk, M.D., has been named chair of the Department of Bone Marrow Transplantation and Cellular Therapy at St. Jude Children’s Research Hospital 26
Mar 24, 2016: Souplantation, Sweet Tomatoes Shatter Goal, Raise $300,000 for St. Jude Children’s Research Hospital to Fight Childhood Cancer, Other Life-Threatening Diseases 27
Government and Public Interest 28
May 03, 2017: St. Jude maps genome organization to link retinal development and retinoblastoma 28
Apr 11, 2017: Success of sensory cell regeneration raises hope for hearing restoration 30
Sep 30, 2016: NHLBI Awards Grants to Help Improve Health Outcomes for Teens, Adults with Sickle Cell Disease 32
Aug 15, 2016: CRISPR gene editing reveals new therapeutic approach for sickle cell disease 33
Mar 01, 2016: Protein revealed as glue that holds biomolecules within the nucleolus 34
Feb 26, 2016: New brain cancer types emerge based on molecular characteristics 36
Feb 15, 2016: Discovery lays the foundation to expand personalized chemotherapy for leukemia patients 37
Feb 15, 2016: Newly identified genes impact how transplanted stem cells give rise to blood cells 39
Feb 08, 2016: Scientists discover a unique mechanism for a high-risk leukemia 40
Feb 01, 2016: Study finds significant cognitive impairment in adult survivors of childhood brain tumors 42
Jan 29, 2016: Drug counters effects of excessive inflammation arising from immune disorder 44
Jan 28, 2016: Mining the epigenome to identify likely origins of childhood brain tumor subtype 45
Jan 27, 2016: Researchers mine the epigenome to identify likely origins of childhood brain tumor subtype 47
Jan 25, 2016: Discovery reveals how protective immune cells protect themselves 49
Jan 13, 2016: New drug target identified for X-linked lymphoproliferative disease 50
Jan 11, 2016: Scientists identify protein interaction that defines an aggressive brain tumor subtype 51
Product News 53
Mar 14, 2016: St. Jude research will guide development of new anti-influenza drugs 53
Other Significant Developments 55
Aug 30, 2017: St. Jude unveils powerful resource to advance treatment of pediatric solid tumors 55
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57

List of Tables
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare, Key Facts 2
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
St. Jude Children’s Research Hospital Inc, Deals By Therapy Area, 2011 to YTD 2017 9
St. Jude Children’s Research Hospital Inc, Medical Devices Deals, 2011 to YTD 2017 11
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Serum Institute of India Enters into Licensing Agreement with St. Jude Children’s Research Hospital 13
NanoViricides Enters into Agreement with St. Jude Children's Research Hospital 14
Cesca Therapeutics Enters into Agreement with St. Jude Children's Research Hospital 15
Eisai Enters into Research Agreement with St. Jude Children's Research Hospital and Medicines For Malaria Venture to Develop SJ733 16
Retrophin Enters Into Research Agreement With St. Jude Children's Research Hospital 17
Calimmune Enters into Licensing Agreement with St. Jude Children’s Research Hospital 18
Juno Therapeutics Enters into Licensing Agreement with St. Jude Children’s Research Hospital 19
Ultragenyx Pharmaceutical Enters Into Licensing Agreement with St. Jude Children’s Research Hospital 20
BioMarin Pharma Enters Into Licensing Agreement With University College London And St. Jude Children's Research Hospital For Hemophilia A Gene Therapy Program 21
St. Jude Children’s Research Hospital Inc, Key Competitors 23
St. Jude Children’s Research Hospital Inc, Key Employees 24

★海外企業調査レポート[St. Jude Children’s Research Hospital Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Steel Authority of India Ltd:企業の戦略・SWOT・財務情報
    Steel Authority of India Ltd - Strategy, SWOT and Corporate Finance Report Summary Steel Authority of India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Bow Energy Pty Ltd:企業の戦略的SWOT分析
    Bow Energy Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Kathmandu Holdings Limited:企業の戦略・SWOT・財務情報
    Kathmandu Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Kathmandu Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Shinsei Bank Ltd:企業のM&A・事業提携・投資動向
    Shinsei Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shinsei Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Premaitha Health Plc (NIPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that a …
  • iCardiac Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary iCardiac Technologies Inc (iCardiac) is a provider of medical laboratory services. The company’s services portfolio include cardiac safety and respiratory services, cardiac safety assessment methodology, clinical trials, electrophysiology, drug development, regulatory services, protocol deve …
  • Engineers India Limited (ENGINERSIN):企業の財務・戦略的SWOT分析
    Engineers India Limited (ENGINERSIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • QPS Austria GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary QPS Austria GmbH (QPS), a subsidiary of QPS Holdings LLC, is a contract research organization (CRO) which provides preclinical and clinical research services. The company offers in vivo services which include generating, characterizing and maintaining transgenic disease models and use them f …
  • NewMarket Corp (NEU):企業の財務・戦略的SWOT分析
    NewMarket Corp (NEU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • TIM SpA (TIT):企業の財務・戦略的SWOT分析
    TIM SpA (TIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Westell Technologies Inc (WSTL):企業の財務・戦略的SWOT分析
    Summary Westell Technologies Inc (Westell) provides network infrastructure solutions. It provides wireless infrastructure solutions such as in-building wireless, communication network solutions, optima management system, and intelligent site management solutions. The company’s in-building wireless p …
  • Vonage Holdings Corp:企業の戦略・SWOT・財務情報
    Vonage Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary Vonage Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sonic Healthcare Ltd (SHL):企業の財務・戦略的SWOT分析
    Sonic Healthcare Ltd (SHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Paion AG (PA8):企業の財務・戦略的SWOT分析
    Summary Paion AG (Paion) is a specialty pharmaceutical company that focuses on the development and commercialization of drugs used for out-patient and hospital-based sedation, anesthesia and critical care services. The company’s lead product, remimazolam, is designed for the treatment of patients re …
  • Agile Therapeutics Inc (AGRX):企業の財務・戦略的SWOT分析
    Summary Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its p …
  • Arcato Laboratories Inc-医療機器分野:企業M&A・提携分析
    Summary Arcato Laboratories Inc (Arcato Laboratories) is an oral health company that commercializes proprietary oral care products for specialty healthcare. The company’s product includes OraWax, a medical device that is used for the treatment of irritation and oral discomfort caused from the use of …
  • Spectra Energy Partners LP (SEP):石油・ガス:M&Aディール及び事業提携情報
    Summary Spectra Energy Partners LP (Spectra Energy), a subsidiary of Enbridge Inc., is a master limited partnership operating in mid-stream energy. The company conducts transmission, storage and gathering of natural gas. It also carries out the transportation and storage of crude oil. Spectra Energy …
  • Aerospace Industrial Development Corporation:企業の戦略・SWOT・財務情報
    Aerospace Industrial Development Corporation - Strategy, SWOT and Corporate Finance Report Summary Aerospace Industrial Development Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Alon USA Energy Inc (ALJ):企業の財務・戦略的SWOT分析
    Alon USA Energy Inc (ALJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Heat Biologics Inc (HTBX)-製薬・医療分野:企業M&A・提携分析
    Summary Heat Biologics Inc (Heat Biologics) is an immuno-oncology company that develops novel therapies to activate patient’s immune system against cancer. The company develops immune pan-antigen cytotoxic therapy, which is a therapeutic vaccine used in the treatment of cancer and infectious disease …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆